In keeping with its commitment to bring quality healthcare using the latest medical technology, Aster CMI Hospital in association with the Indian Institute of Science (IISc) launched an Artificial Intelligence (AI) lab today. The Aster-AI lab is a collaborative lab, set up with the aim to build cutting edge AI products in the healthcare domain and bridge the gap between clinical medicine and technology by training healthcare professionals in AI. Dr. Azad Moopen, Founder Chairman and Managing

Fullscript, the leading care delivery platform for integrative medicine, today announced it has completed the acquisition of Emerson Ecologics, a long-standing player in the integrative healthcare industry. This transaction nearly doubles the annual revenue of Fullscript and doubles the number of integrative medicine patients and practitioners Fullscript supports to more than 70,000 healthcare professionals and over 5 million patients. "This acquisition is a giant step toward b

PAVmed Inc., a diversified commercial-stage medical technology company, today announced that physicians at the Clinica Porto Azul in Barranquilla, Colombia successfully implanted the Company’s PortIO™ Intraosseous Infusion System in three patients—the first human implants of the device—as part of its IRB-approved first-in-human (FIH) clinical study of up to 40 patients. All patients have also undergone successful infusion of fluids consistent with the study protocol an

InterSystems, a creative data technology provider dedicated to helping customers solve the most critical scalability, interoperability and speed problems, today announced that EMC Healthcare, a subsidiary of EMTEK Group, has selected InterSystems to digitize healthcare information across its private hospital group for world-class patient care and experience. Working in partnership, InterSystems and EMC will implement the InterSystems TrakCare® unified healthcare information syst

Glooko Inc., a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can work together to improve health outcomes. DIABNEXT's mobile app complements Glooko's product portfolio and tracks diabetes data so t

Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH SARS-CoV-2/S Test. Minute Molecular’s polymerase chain reaction (PCR) test operates on a small instrument called the DASH Analyzer, which consolidates the entire PCR testing process (sample extraction and PCR) providing a result in approximately 15 minutes. “We are pleased with the FDA’s decision and are rampi

CoreTissue BioEngineering Inc., a medical device company developing an artificial ligament derived from decellularized animal tissue, was accepted into Johnson & Johnson Innovation - JPOD @ Boston. CoreTissue BioEngineering will expand its footprint and accelerate business development in the US through its support team and select key opinion leaders (KOLs). About CoreTissue BioEngineering Inc. Based in Yokohama, Japan, CoreTissue BioEngineeri

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today the first surgical cases of DYNA-LINK Titanium with Barb Fixation. DYNA-LINK Titanium Stand-Alone Anterior Lumbar System is a zero-profile, stand-alone device that offers surgeons a safe and reliable alternative to 360o fusion procedures. In addition to providing immediate fixation, multiple footprints, heights, scr

ABEC , a leading global provider of biomanufacturing engineering solutions and services, announced today that it will supply custom large-scale, large-scale products to EKF Life Sciences , a division of EKF Diagnostics Holdings plc Bioprocessing equipment including a stainless steel fermenter with a total volume of 14,500 liters and an 8,000 liter media preparation system. EKF Life Sciences produces diagnostic enzymes and contract custom products for use in the medical diagnostic, pharmaceuti

Guardant Health, Inc, a leading precision oncology company, today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted regulatory approval of Guardant360® CDx, a liquid biopsy test for tumor mutation profiling, also known as comprehensive genomic profiling, in patients with advanced solid tumors MHLW also approved Guardant360 CDx as a companion diagnostic to identify patients with microsatellite instability-high (MSI-High) solid tumors who may be